Nuveen Asset Management, LLC Rubius Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $145,969 - $1.1 Million	-184,772 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $43,018 - $105,268	10,122 Added 5.8%	184,772 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $289,664 - $530,851	29,924 Added 20.68%	174,650 $1.69 Million
Q3 2021 Nov 12, 2021	SELL	$17.6 - $25.91 $53,961 - $79,440	-3,066 Reduced 2.07%	144,726 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$22.26 - $28.43 $260,464 - $332,659	-11,701 Reduced 7.34%	147,792 $3.61 Million
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $152,211 - $607,517	-18,979 Reduced 10.63%	159,493 $4.23 Million
Q4 2020 Feb 16, 2021	SELL	$4.23 - $8.73 $3,151 - $6,503	-745 Reduced 0.42%	178,472 $1.35 Million
Q3 2020 Nov 16, 2020	BUY	$4.65 - $6.25 $181,215 - $243,568	38,971 Added 27.79%	179,217 $897,000
Q2 2020 Aug 14, 2020	SELL	$4.01 - $6.88 $224,379 - $384,970	-55,955 Reduced 28.52%	140,246 $839,000
Q1 2020 May 14, 2020	BUY	$3.74 - $9.84 $4,271 - $11,237	1,142 Added 0.59%	196,201 $873,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $453,472 - $885,620	62,721 Added 47.39%	195,059 $1.85 Million
Q3 2019 Nov 14, 2019	BUY	$7.85 - $15.75 $56,174 - $112,707	7,156 Added 5.72%	132,338 $1.04 Million
Q2 2019 Aug 15, 2019	BUY	$13.5 - $19.94 $1.69 Million - $2.5 Million	125,182 New	125,182 $1.97 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.